课题基金 / 基金详情

Type II: I-Corps Site at Carnegie Mellon University: A Model Promoting University Innovation, Entrepreneurship, and Regional Growth

Type II: I-Corps Site at Carnegie Mellon University: A Model Promoting University Innovation, Entrepreneurship, and Regional Growth
第二类:卡内基梅隆大学 I-Corps 基地:促进大学创新、创业和区域发展的典范
批准号:
1735702
负责人:
Melanie Simko
金额:
$29.96万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2022-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
这个项目来自卡内基梅隆大学,在这个机构创建了一个I-Corps站点。美国国家科学基金会创新队(I-Corps)站点是由美国国家科学基金会资助的实体,建立在大学里,其目的是培养和支持多个本地团队,将他们的技术概念转化为市场。网站提供基础设施、建议、资源、网络机会、培训和适度的资金,使团体能够将他们的工作转化为市场或成为I-Corps团队的申请人。I-Corps站点还加强地方和区域创新,并为由导师、研究人员、企业家和投资者组成的国家创新网络做出贡献。这是一项第二类建议,要求“续期”现有第一类军团遗址的资金。I-Corps Site建议有两种类型。第一类建议是由以前没有获得I- corps Site资助的机构提交的。这些建议可能要求每年10万美元,为期五年。第二类建议是由先前获得资助的机构提交的。这些建议可能要求每年至多10万美元,为期三年。CMU I-Corps网站的主要目标是建立一个适用于全国其他大学和地区的综合项目;一个利用和增加当地资源并整合到国家科学基金会I-Corps项目中的项目。为此,CMU I-Corps站点与区域站点和国家节点网络合作,准备团队进入国家I-Corps培训计划。CMU I-Corps站点模型课程结合了专注于客户发现和产品适应的敏捷方法,并提供了有效的指导,与区域利益相关者的强有力合作,以及将项目和区域合作伙伴的观点结合起来。目标是创建一个由学生、教师和社区成员组成的创业社区,他们不仅能直接从该项目中受益,还能成为指导和建议他人的专家。CMU I-Corps站点加速了大学研究向成功商业企业的有效转移,使政府资助的大学研究和创新能够促进区域增长并造福公众。许多行业都有助于获得收益,例如医疗保健、交通、能源和可持续发展。结合地区专业知识和合作对大学和社区都有好处,并有助于扩大参与。该计划提供了一个适应性强的模式,以加强大学、地区和国家的创业和创新生态系统。
英文摘要
This project, from Carnegie Mellon University, creates an I-Corps Site at this institution. NSF Innovation Corps (I-Corps) Sites are NSF-funded entities established at universities whose purpose is to nurture and support multiple, local teams to transition their technology concepts into the marketplace. Sites provide infrastructure, advice, resources, networking opportunities, training and modest funding to enable groups to transition their work into the marketplace or into becoming I-Corps Team applicants. I-Corps Sites also strengthen innovation locally and regionally and contribute to the National Innovation Network of mentors, researchers, entrepreneurs and investors.This is a Type II proposal, requesting a "renewal" of funding for an existing I-Corps Site. There are two types of I-Corps Site proposals. Type I proposals are submitted by institutions that have not had prior funding as an I-Corps Site. These proposals may request $100,000 per year for up to five years. Type II proposals are submitted by institutions that have had prior funding as an I-Corps Site. These proposals may request up to $100,000 per year for up to three years.A primary goal of the CMU I-Corps Site is to build a comprehensive program that is adaptable to other universities and regions across the country; one that leverages and augments local resources and that integrates into the NSF I-Corps program. To this end, the CMU I-Corps Site works with a network of regional Sites and national Nodes to prepare teams to enter the National I-Corps training program. The CMU I-Corps Site model curriculum incorporates an agile methodology focused on customer discovery and product adaptation, and provides effective mentoring, strong collaborations with regional stakeholders, and the incorporation of programs and perspectives of regional partners. A goal is to create an entrepreneurial community of students, faculty and community members who not only benefit directly from the program, but also become experts in mentoring and advising others. The CMU I-Corps Site accelerates the effective transfer of university research into successful commercial ventures, enabling government funded university research and innovations to promote regional growth and benefit the public. Many sectors serve to gain, for example, healthcare, transportation, energy, and sustainability. Incorporating regional expertise and collaboration benefits both the university and the community and helps broaden participation. The program provides an adaptable model to strengthen the entrepreneurial and innovation ecosystem of universities, their regions and the nation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
  • 批准号:
    2026JJ30126
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    杨沙
  • 依托单位:
肿瘤侵袭边界SERPINA3+MHC-II+胶质细胞驱动GBM免疫抑制的机制研究
  • 批准号:
    82674293
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    武明花
  • 依托单位: